KRAS mutation: from undruggable to druggable in cancerLamei Huang, Liwu Fu|Signal Transduction and Targeted Therapy|2021Cited by 1k
Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2Chun-ling Dai, Liwu Fu, Amit K. Tiwari et al.|Cancer Research|2008Cited by 385
Apatinib (YN968D1) Reverses Multidrug Resistance by Inhibiting the Efflux Function of Multiple ATP-Binding Cassette TransportersYan‐jun Mi, Liwu Fu|Cancer Research|2010Cited by 348
Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancersYuan Lin, Guangmei Yan, Fang Wang et al.|Proceedings of the National Academy of Sciences|2014Cited by 167
Intercellular transfer of exosomal wild type EGFR triggers osimertinib resistance in non-small cell lung cancerShaocong Wu, Liwu Fu|Molecular Cancer|2021Cited by 140